PULMONARY BLASTOMYCOSIS

This adverse event was reported 115 times

PULMONARY BLASTOMYCOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERAVACYCLINE 2 0.0067
1 THIOTEPA 8 0.0008
2 AMPHOTERICIN B 7 0.0005
3 MYCOPHENOLATE MOFETIL 64 0.0005
4 MICAFUNGIN SODIUM 3 0.0005
5 TACROLIMUS OINTMENT 0.1% 57 0.0004
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 57 0.0004
7 TACROLIMUS 57 0.0004
8 ANTI-THYMOCYTE GLOBULIN (RABBIT) 2 0.0002
9 VORICONAZOLE 7 0.0002
See all drugs enriched for association with PULMONARY BLASTOMYCOSIS